GeneDx Holdings Corp. is 1.4x more valuable than Pennant Group, Inc. by market capitalization ($1.61 B vs $1.14 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | WGS | PNTG |
|---|---|---|
| Market cap | $1.61 B | $1.14 B |
| US-listed rank | #2259 | #2542 |
| Revenue (latest FY) | $427.54M | $947.71M |
| Net income (latest FY) | -$21.00M | $29.58M |
| Net margin | -4.9% | 3.1% |
| P/E (trailing FY) | - | 38.4 |
| SEC filings | 748 | 500 |
GeneDx Holdings Corp. is 1.4x more valuable than Pennant Group, Inc. by market capitalization ($1.61 B vs $1.14 B).
In their latest fiscal years, GeneDx Holdings Corp. reported $427.54M in revenue while Pennant Group, Inc. reported $947.71M.
Full pages: GeneDx Holdings Corp. and Pennant Group, Inc., or browse the full rankings.